Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics

ALNY POWR Grades

• ALNY scores best on the Growth dimension, with a Growth rank ahead of 74.18% of US stocks.
• The strongest trend for ALNY is in Quality, which has been heading up over the past 52 weeks.
• ALNY ranks lowest in Momentum; there it ranks in the 8th percentile.

ALNY Stock Summary

• ALNY's price/sales ratio is 28.85; that's higher than the P/S ratio of 92.76% of US stocks.
• With a year-over-year growth in debt of 130.82%, Alnylam Pharmaceuticals Inc's debt growth rate surpasses 92.56% of about US stocks.
• As for revenue growth, note that ALNY's revenue has grown 86.87% over the past 12 months; that beats the revenue growth of 92.08% of US companies in our set.
• Stocks that are quantitatively similar to ALNY, based on their financial statements, market capitalization, and price volatility, are QRVO, GNTX, IPGP, BGNE, and WDC.
• ALNY's SEC filings can be seen here. And to visit Alnylam Pharmaceuticals Inc's official web site, go to www.alnylam.com.

ALNY Valuation Summary

• ALNY's price/earnings ratio is -27; this is 173.97% lower than that of the median Healthcare stock.
• ALNY's EV/EBIT ratio has moved down 28.4 over the prior 210 months.
• Over the past 210 months, ALNY's price/sales ratio has gone down 400.7.

Below are key valuation metrics over time for ALNY.

ALNY Growth Metrics

• Its 5 year price growth rate is now at 143.95%.
• The 3 year revenue growth rate now stands at 188.59%.
• Its 3 year cash and equivalents growth rate is now at 213.46%.

ALNY's revenue has moved up $646,437,000 over the prior 67 months.

The table below shows ALNY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	687.534	-590.986	-886.681
2021-03-31	570.943	-604.46	-876.351
2020-12-31	492.853	-614.961	-858.281
2020-09-30	400.972	-687.797	-890.926
2020-06-30	345.18	-760.103	-846.17
2020-03-31	285.932	-336.078	-886.422

ALNY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ALNY has a Quality Grade of C, ranking ahead of 30.65% of graded US stocks.
• ALNY's asset turnover comes in at 0.22 -- ranking 188th of 681 Pharmaceutical Products stocks.
• QGEN, TXMD, and KMDA are the stocks whose asset turnover ratios are most correlated with ALNY.

The table below shows ALNY's key quality metrics over time.